We use cookies to enhance your working experience with us. To find out more - be sure to confer with our privateness policy. Furthermore, the conolidine molecule did not interact with the classical receptors, which means that it would not compete against opioid peptides to bind to these receptors. https://proleviate-uses-fda-appro55410.bloggactif.com/31780387/not-known-details-about-conolidine